Alcon AG | ALC - Ebit

Stock Price
50.42
Daily Change
0.81 1.63%
Monthly
-21.10%
Yearly
-31.94%
Q2 Forecast
49.42

Alcon AG reported $297M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AstraZeneca USD 7.11B 4.14B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GRIFOLS EUR 249M 103.11M Mar/2026
Lonza CHF 673M 54M Jun/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.18B 118M Mar/2026
Philips EUR 302M 417M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025
Sonova Holding CHF 296.8M 156.9M Dec/2025
UCB EUR 1.29B 571M Dec/2025